BAX Cancer Research Results
BAX, Apoptosis regulator BAX: Click to Expand ⟱
| Source: |
| Type: Proapototic protein |
BAX is a member of the Bcl-2 gene family.
Pro-apoptotic protein that forms heterodimers with anti-apoptotic BCL2 proteins; involved in various cellular activities and regulated by p53; mediates the release of cytochrome c from mitochondria.
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
tumCV↓, CSCs↓, selectivity↑, Apoptosis↑, ROS↑, LDH↓, Casp3↑, BAX↑, Bak↑, cMyc↑, MMP↓,
ROS↑, Casp3↑, Casp9↑, Casp6↑, GSH↓, SOD↓, GPx↓, MMP↓, P53↑, P21↑, Cyt‑c↑, BID↑, BAX↑, Bcl-2↓, Bcl-xL↓, Akt↓, Raf↓, ERK↓, MAP2K1/MEK1↓, JNK↑, p38↑,
ROS↑, Dose↝, Bcl-2↓, BAX↑, ER Stress↑,
eff↑, ROS↑, Casp8↓, Casp9↑, BAX↑, Cyt‑c↑, Bcl-2↓, AKT1↓,
tumCV↓, BAX↑, BID↑, BOK↑, APAF1↑, TNF-α↑, FasL↑, Fas↑, FADD↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Mcl-1↓, NAIP↓, Bcl-2↓, CDK4↓, CycB/CCNB1↓, cycD1/CCND1↓, cycE1↓, TRAIL↑, p‑Akt↓, Akt↓, mTOR↓, PDK1↓, BAD↓, GSK‐3β↑, AMPK↑, p27/CDKN1B↑, P53↑,
eff↑, Dose∅, ROS↑, DNAdam↑, P53↑, P21↑, BAX↑, Dose∅,
TumCCA↑, STAT3↓, P21↑, IGFBP7↑, Akt↓, mTOR↓, ROS↑, DNAdam↑, P53↑, P21↑, BAX↑,
tumCV↓, Apoptosis↑, TumCCA↑, GRP78/BiP↑, GRP94↑, CEBPA↑, CHOP/DDIT3↑, Ca+2↑, Casp12↑, Casp9↑, Casp3↑, Cyt‑c↑, BAX↑, Bcl-2↓, ER Stress↑, MMP↓,
TumCP↓, LDH↝, ChemoSen↑, RadioS↑, Casp3↑, BAX↑, Cyt‑c↑, Casp9↑, Bcl-2↓, COX2↓, IL1β↓, ROS↑, NF-kB↓, COX2↓, TumCCA↓, Thiols↓, GSH↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
BC, |
MCF-10AT |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
MMP↓, Casp↑, BAX↑, Ca+2↑, ROS↑, cJun↑,
tumCV↓, TumAuto↑, Casp3↑, BAX↑, Beclin-1↑, ATG3↑, ATG5↑, Bcl-2↓, mTOR↓, PI3K↓, Akt↓, PTEN↑, ROS↑, MMP↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Cerv, |
SiHa |
|
|
|
P53↑, P21↑, BAX↑, Casp3↑, Casp7↑, TumCCA↑, ROS↑, TumCCA↑, Apoptosis↑,
| - |
in-vitro, |
Cerv, |
INT-407 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
AntiCan↑, TumCG↓, ROS↑, Apoptosis↑, TumCMig↓, CTNNB1↓, Twist↓, Bcl-2↓, survivin↓, NF-kB↓, Sp1/3/4↓, BAX↑, P21↑, P53↑, eff↓, TumCMig↓,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GPx↓, 1, GSH↓, 2, ROS↑, 11, SOD↓, 1, Thiols↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
BOK↑, 1, MMP↓, 5, Raf↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AKT1↓, 1, AMPK↑, 1, cMyc↑, 1, LDH↓, 1, LDH↝, 1, PDK1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 4, p‑Akt↓, 1, APAF1↑, 1, Apoptosis↑, 4, BAD↓, 1, Bak↑, 1, BAX↑, 13, Bcl-2↓, 8, Bcl-xL↓, 1, BID↑, 2, Casp↑, 1, Casp12↑, 1, Casp3↑, 7, Casp6↑, 1, Casp7↑, 2, Casp8↓, 1, Casp8↑, 1, Casp9↑, 5, Cyt‑c↑, 4, FADD↑, 1, Fas↑, 1, FasL↑, 1, JNK↑, 1, Mcl-1↓, 1, NAIP↓, 1, p27/CDKN1B↑, 1, p38↑, 1, survivin↓, 1, TRAIL↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
cJun↑, 1, tumCV↓, 4,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1, ER Stress↑, 2, GRP78/BiP↑, 1, GRP94↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG3↑, 1, ATG5↑, 1, Beclin-1↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 2, P53↑, 6,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 1, cycE1↓, 1, P21↑, 6, TumCCA↓, 1, TumCCA↑, 4,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CEBPA↑, 1, CSCs↓, 1, CTNNB1↓, 1, ERK↓, 1, GSK‐3β↑, 1, IGFBP7↑, 1, MAP2K1/MEK1↓, 1, mTOR↓, 3, PI3K↓, 1, PTEN↑, 1, STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 2, TumCMig↓, 2, TumCP↓, 1, Twist↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 2, IL1β↓, 1, NF-kB↓, 2, TNF-α↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 1, Dose∅, 2, eff↓, 1, eff↑, 2, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
LDH↓, 1, LDH↝, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1,
Total Targets: 93
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: BAX, Apoptosis regulator BAX
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:26 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page